HsuehAJWJonesPBC. Extrapituitary actions of gonadotropin-releasing hormone. Endocr Rev1981; 2: 437–61.
2.
HarrisALCarmichaelJCantwellBMJDowsettM. Zoladex: endocrine and therapeutic effects in postmenopausal breast cancer. Br J Cancer1989; 59: 97–9.
3.
BeattieCWCorbinA. Contraceptive activity of LH-RH in the rat. Biol Reprod1977; 16: 333–7.
4.
JonsonEGendrichRWhiteW. Delay of puberty and inhibition of reproductive processes in the rat by gonadotropin-releasing hormone agonistic analog. Fertil Steril1976; 27: 853–60.
5.
JonsonESSteelyJHWhiteERDeSomberER. Endocrine-dependent rat mammary tumor regression: use of a gonadotropin-releasing hormone analog. Science1976; 194: 329–33.
6.
RivierCRivierJValeWW. Chronic effects of [D-Trp6-Pro9-NEt] luteinizing hormone-releasing factor on reproductive processes in the female rat. Endocrinology1978; 103: 2299–305.
7.
KledzikOSCussanLAuclairCKellyPALabrieF. Inhibitory effect of a luteinizing (LH)-releasing hormone agonist on rat ovarian LH and follicle-stimulating hormone receptor levels during pregnancy. Fertil Steril1978; 29: 560–5.
8.
CusanLAuclairCBelangerAFerlandLKellyPASequinCInhibitory effects of long term treatment with a luteinizing hormone-releasing hormone agonist on the pituitary-gonadal axis in male and female rats. Endocrinology1979; 104: 1369–76.
9.
NilliusSBergquistCWideL. Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue; a new approach to birth control?Contraception1978; 17: 538–45.
10.
LemayALabrieFFerlandLRaynaudJP. Possible leuteolytic effects of luteinizing hormone-releasing hormone in normal women. Fertil Steril1979; 31: 29–34.
11.
CorbinABeattieCWReesRYardleyJFoellTChaiSYPostcoital contraceptive effects of agonist analogs of luteinizing hormone-releasing hormone. Fertil Steril1977; 28: 471–5.
12.
ContiMHarwoodJPHsuehAJWDufauMLBattKJ. Gonadotropin-induced loss of hormone receptors and desensitization of adenylate cyclase in the ovary. J Biol Chem1976; 251: 7729–31.
13.
ContiMHarwoodJDufauMLCattKJ. Regulation of luteinizing hormone receptors and adenylate cyclase activity by gonadotropin in the rat ovary. Mol Pharmacol1977; 13: 1024–32.
14.
RippelRHJohnsonES. Regression of corpora lutea in the rabbit after injection of a gonadotropin-releasing peptide. Proc Soc Exp Biol Med1976; 152: 432–6.
15.
BanikUKGivnerML. Ovulation induction and antifertility effects of an LH-RH analogue (AY-25, 205) in cyclic rats. J Reprod Fertil1975; 44: 87–91.
16.
HsuehAJWEricksonGF. Extrapituitary actions of gonadotropin-releasing hormone: direct inhibition of ovarian steroidogenesis. Science1979; 204: 854–5.
17.
ClaytonRNHarwoodJPCattKJ. Gonadotropin-releasing hormone analogue binds to luteal cells and inhibits progesterone production. Nature1979; 282: 90–2.
18.
DavisJSWestLAFareseRV. Gonadotropin-releasing hormone (Gn-RH) rapidly stimulates the formation of inositol phosphates and diacylgycerol in rat granulosa cells: further evidence for the involvement of Ca2+ and protein kinase C in the action of Gn-RH. Endocrinology1986; 118: 2561–71.
ImaiAIidaKTamayaT. Direct action of gonadotropin-releasing hormone (Gn-RH) analogue on ovary: an alternative acting mechanism of buserelin. Arch Gynecol Obstet1991; 248: 117–21.
21.
IidaKImaiATamayaT. Stimulatory effects of estrogen on gonadotropin-releasing hormone-induced phosphoinositide turnover in granulosa cells. J Steroid Biochem Mol Biol1991; 38: 583–6.
22.
ShinoharaOKnechtMCattKJ. Inhibition of gonadotropin-induced granulosa cell differentiation by activation of protein kinase C. Proc Natl Acad Sci USA1985; 82: 8518–22.
23.
WangJLeeVLeungPCK. Differential role of protein kinase C in the action of luteinizing hormone-releasing hormone on hormone production in rat ovarian cells. Am J Obstet Gynecol1989; 160: 984–9.
24.
VelduisJDDemersLM. An inhibitory role for the protein kinase C pathway in ovarian steroidogenesis: studies with cultured swine granulosa cells. Biochem J1986; 239: 505–11.
25.
ImaiAIidaKTamayaT. Gonadotropin-releasing hormone has a biphasic action on aromatase activity through protein kinase C in granulosa cells. Int J Fertil (in press).
26.
HorsthemkeBKnisatshekHRivierJSandowJBauerK. Degradation of luteinizing hormone-releasing hormone and analogus by adenohypophyseal peptidases. Biochem Biophys Res Commun1981; 100: 753–9.
27.
MarksNSternF. Enzymatic mechanism for the inactivation of luteinizing hormone-releasing hormone (LH-RH). Biochem Biophys Res Commun1974; 61: 1458–63.
28.
PrimstoneBEpsteinSHamiltonSMLeRoithDHendricksS. Metabolic clearance and plasma half disappearance time of exogenous gonadotropin releasing hormone in normal subjects and in patients with liver disease and chronic renal failure. J Clin Endocrinol Metab1977; 44: 356–60.
29.
JeffcoateSGreenwoodRHollandD. Blood and urine clearance of luteinizing hormone releasing hormone in man measured by radioimmunoassay. J Endocrinol1974; 60: 305–14.
30.
ImaiAIidaKTamayaT. Tight coupling of gonadotropin-releasing hormone receptor to stimulated phosphoinositide turnover and antigonadotropic action. Gynecol Obstet Invest1992; 33: 36–41.
31.
AtenRFIrelandJ JWeemsCWBehrmanHR. Presence of gonadotropin-releasing hormone-like proteins in bovine and ovine ovaries. Endocrinology1987; 120: 1727–33.
32.
YingSLingNBohlenPGuilleminR. Gonadocrinine: peptides in ovarian follicular fluid stimulating the secretion of pituitary gonadotropins. Endocrinology1981; 108: 1206–331.
33.
NikolicsKMasonAJSönyiERamachadranJSeeburgPH. A prolactin-inhibiting factor within the precursor for human gonadotropin-releasing hormone. Nature1985; 316: 511–17.
34.
SeeburgPHAdelmanJP. Characterization of cDNA for precursor of human luteinizing hormone releasing hormone. Nature1985; 311: 666–8.
35.
WaxmanJHHarlandSJCoombesRCWrigleyPFMMalpasJSListerTA. The treatment of postmenopausal women with advanced breast cancer with buserelin. Cancer Chemother Pharmacol1985; 15: 171–3.
36.
KlijinJMGDe JongFH. Treatment with a luteinizing hormone-releasing hormone analogue (buserelin) in premenopausal patients with metastatic breast cancer. Lancet1982; i: 1213–16.
37.
PresentCASolowayMSKliozeSSKosolaJWYakabowALMendezRGBuserelin as primary therapy in advanced prostatic carcinoma. Cancer1985; 56: 2416–19.
38.
SchröderFH. Hormonal manipulation of prostatic cancer: too soon for total androgen blockade?BMJ1991; 303: 1489–90.
39.
GallagherCJOliverRTDOramDHFowlerCGBlakePRMantellBSA new treatment for endometrial cancer with gonadotropin releasing hormone analogue. Br J Obstet Gynecol1991; 98: 1037–41.
40.
ParmarHRustinGLightmanSLPhillipsRHHanhamIWSchallyAV. Response to D-Try-6-luteinizing hormone releasing hormone (Decapeptyl) microcapsules in advanced ovarian cancer. BMJ1988; 296: 1229.
41.
GreenwayBA. Carcinoma of the exocrine pancreas: a sex hormone responsive tumour?Br J Surg1987; 74: 441–2.
42.
EideneKAFlanaganCAHarrisNSMillarRP. Gonadotropin-releasing hormone (Gn-RH)-binding sites in human breast cancer cell lines and inhibitory effects of Gn-RH antagonists. J Clin Endocrinol Metab1987; 64: 425–32.
43.
SharoniYBosinELevyMJSchallyAV. Inhibition of growth of human mammary tumor cells by potent antagonists of luteinizing hormone-releasing hormone. Proc Natl Acad Sci USA1989; 86: 1648–51.
44.
SzendeBSrkalovicGSchallyAVLapisKGrootK. Inhibitory effects of analogs of luteinizing hormone-releasing hormone and somatostatin on pancreatic cancers in hamsters. Cancer1990; 65: 2279–90.
45.
SrkalovicGSzendeBReddingTWGrootKSchallyAV. Receptors for D-Trp6-luteinizing hormone-releasing hormone, somatostatin, and insulin-like growth factor I in MXT mouse mammary carcinoma. Proc Soc Exp Biol Med1989; 192: 209–18.
46.
SrkalovicGWittliffJLSchallyAV. Detection and partial characterization of receptors for [D-Trp6]-luteinizing hormone-releasing hormone and epidermal growth factor in human endometrial carcinoma. Cancer Res1990; 50: 1841–6.
47.
SzendeBSrkalovicGTimarJMulchaheyJJNeillJDLapisKLocalization of receptors for luteinizing hormone-releasing hormone in pancreatic and mammary cancer cells. Proc Natl Acad Sci USA1991; 88: 4153–6.
48.
LiebowCLeeMTKamerARSchallyAV. Regulation of luteinizing hormone-releasing hormone receptor binding by heterogeneous and autologous receptor-stimulated tyrosine phosphorylation. Proc Natl Acad Sci USA1991; 88: 2244–8.
49.
LeeMTLiebowCHKamerARSchallyAV. Effects of epidermal growth factor and analogues of luteinizing hormone-releasing hormone and somatostatin on phosphorylation and dephosphorylation of tyrosine residues of specific protein substrates in various tumors. Proc Natl Acad Sci USA1991; 88: 1656–60.